trending Market Intelligence /marketintelligence/en/news-insights/trending/5kgZN_jt053GJLyfgaP_Fw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Atara Biotherapeutics CEO to step down

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Atara Biotherapeutics CEO to step down

Atara Biotherapeutics Inc. said Isaac Ciechanover has decided to step down as president and CEO.

Ciechanover will keep serving at Atara Biotherapeutics until June 30 or until the appointment of a replacement. He became president and CEO of Atara Biotherapeutics in August 2012.

The company's board has formed a search committee to evaluate candidates for the CEO position.

Atara develops cancer treatments. Its most advanced T cell immunotherapy, tab-cel, is being studied for treating patients with Epstein-Barr virus associated with a post-transplant lymphoproliferative disorder as well as other EBV-associated hematologic and solid tumors, including nasopharyngeal carcinoma.